These findings are in concert with previous studies that have also demonstrated increased expression of AGR2 in PanIN lesions [11,27] and pancreatic ductal adenocarcinoma tissues [11,23]. This evidence concerns the gene AGR2 and pancreatic ductal adenocarcinoma.